Suppr超能文献

吡格列酮通过一种不依赖过氧化物酶体增殖物激活受体γ的机制抑制同型半胱氨酸诱导的血管平滑肌细胞迁移。

Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.

作者信息

Li Li, Gao Ping-Jin, Xi Rui, Wu Chun-Fang, Zhu Ding-Liang, Yan Jing, Lu Guo-Ping

机构信息

Intensive Care Unit, Zhejiang Hospital, Hangzhou, China.

出版信息

Clin Exp Pharmacol Physiol. 2008 Dec;35(12):1471-6. doi: 10.1111/j.1440-1681.2008.05025.x. Epub 2008 Aug 26.

Abstract
  1. Peroxisome proliferator-activated receptor (PPAR)-gamma agonists have been demonstrated to exert protective effects against homocysteine (Hcy)-induced pathogenesis. However, the effects of PPAR-gamma agonists on Hcy-induced migration are unknown. In the present study, we examined the effect of pioglitazone on the migration of vascular smooth muscle cells (VSMC) induced by Hcy and the possible mechanism involved. 2. Vascular smooth muscle cells were isolated from the thoracic aortas of male Sprague-Dawley rats. The migration of VSMC was examined using a transwell technique. The generation of intracellular reactive oxygen species (ROS) was measured using the ROS-sensitive fluoroprobe 2',7'-dichlorodihydrofluorescein diacetate. The activity of NAD(P)H oxidase was assessed by lucigenin enhanced chemiluminescence. Activation of p38 mitogen-activated protein kinase (MAPK) was determined by western blotting. 3. The results showed that pioglitazone dose-dependently inhibited the migration of VSMC induced by Hcy. This was not reversed by the PPAR-gamma antagonist GW9662. In addition, pretreatment with the NAD(P)H oxidase inhibitor diphenylene iodonium (DPI), the free radical scavenger N-acetylcysteine and the p38 MAPK inhibitor SB202190 blocked Hcy-induced VSMC migration. Furthermore, we observed that pioglitazone suppressed Hcy-induced intracellular ROS production; similar effects were observed with DPI and NAC. Pioglitazone attenuated Hcy-induced activation of NAD(P)H oxidase. Moreover, pioglitazone blocked Hcy-induced p38 MAPK phosphorylation; similar effects were observed for DPI, NAC and SB202190. 4. The data demonstrate that pioglitazone inhibits Hcy-induced VSMC migration that is independent of PPAR-gamma. Furthermore, part of the biological effect of pioglitazone involves a decrease in the levels of NAD(P)H oxidase derived-ROS and p38 MAPK activation.
摘要
  1. 过氧化物酶体增殖物激活受体(PPAR)-γ激动剂已被证明对同型半胱氨酸(Hcy)诱导的发病机制具有保护作用。然而,PPAR-γ激动剂对Hcy诱导的细胞迁移的影响尚不清楚。在本研究中,我们研究了吡格列酮对Hcy诱导的血管平滑肌细胞(VSMC)迁移的影响及其可能的机制。2. 从雄性Sprague-Dawley大鼠的胸主动脉中分离血管平滑肌细胞。使用Transwell技术检测VSMC的迁移。使用ROS敏感荧光探针2',7'-二氯二氢荧光素二乙酸酯测量细胞内活性氧(ROS)的产生。通过光泽精增强化学发光评估NAD(P)H氧化酶的活性。通过蛋白质印迹法测定p38丝裂原活化蛋白激酶(MAPK)的激活。3. 结果表明,吡格列酮剂量依赖性地抑制Hcy诱导的VSMC迁移。PPAR-γ拮抗剂GW9662不能逆转这种作用。此外,用NAD(P)H氧化酶抑制剂二亚苯基碘鎓(DPI)、自由基清除剂N-乙酰半胱氨酸和p38 MAPK抑制剂SB202190预处理可阻断Hcy诱导的VSMC迁移。此外,我们观察到吡格列酮抑制Hcy诱导的细胞内ROS产生;DPI和NAC也有类似作用。吡格列酮减弱Hcy诱导的NAD(P)H氧化酶激活。此外,吡格列酮阻断Hcy诱导的p38 MAPK磷酸化;DPI、NAC和SB202190也有类似作用。4. 数据表明,吡格列酮抑制Hcy诱导的VSMC迁移,且该作用不依赖于PPAR-γ。此外,吡格列酮的部分生物学效应涉及降低NAD(P)H氧化酶衍生的ROS水平和p38 MAPK激活。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验